Anticipated Stigma, Stereotypes, And Covid-19 Testing

Testing for COVID-19 is important for identifying, tracing, and treating COVID-19 cases as well as informing policy decisions. Evidence from other disease epidemics suggests that anticipated stigma and stereotypes are barriers to testing for disease. Anticipated stigma may undermine testing due to labeling avoidance (i.e., efforts to avoid receiving the label of a stigmatized status) and stereotypes may undermine testing by reducing perceived vulnerability to disease. Given the importance of scaling up COVID-19 testing, the current study explored the potential roles of anticipated stigma and stereotypes in COVID-19 testing. A cross-sectional, online survey was conducted with 845 United States adults in April 2020. Measures were adapted from previous studies of stigma associated with infectious diseases, and participants were asked about the likelihood that they would seek a COVID-19 test if one were to be ordered by their doctor. Analyses demonstrated that participants who anticipated greater COVID-19 stigma and endorsed COVID-19 stereotypes to a greater degree reported that they would be less likely to seek a COVID-19 test. Notably, endorsement of anticipated stigma and stereotypes was low, and knowledge and fear were stronger predictors of testing than stigma. Nonetheless, results provide preliminary evidence that anticipated stigma and stereotypes may represent barriers to testing in the context of COVID-19, similar to other diseases. As COVID-19 tests become more widely available, efforts may be needed to address COVID-19 stigma alongside other barriers such as access and knowledge to maximize testing efforts.